reports
- GlobalData Healthcare Department
Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review
Actelion Ltd (ATLN) - Financial and Strategic SWOT Analysis Review Summary Actelion Ltd (Actelion) is a biopharmaceutical company, which strives to discover, develop and commercialize innovative treatments for diseases with considerable unmet medical needs. The company focuses on the development of treatments for pulmonary arterial hypertension (PAH). Its PAH franchise products include endothelin receptor antagonists (ERAs) Tracleer (bosentan), Opsumit (macitentan), Veletri (epoprostenol for i...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.